Merck & Co., Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Merck & Co., Inc. (MRK) reported Increase (Decrease) in Prepaid Expense and Other Assets of $120.00 million for the 9-month period ending 2009-09-30, per its 10-Q filed 2009-10-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2009-10-29
- Merck & Co., Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2009-09-30 was $16.00M.
- Merck & Co., Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2008-09-30 was -$8.00M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month |
|---|---|---|---|
| 2009-09-30 | $16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | $120.00M 10-Q · filed 2009-10-29 | |
| 2009-06-30 | $104.00M 10-Q · filed 2009-07-24 | ||
| 2008-09-30 | -$8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | -$22.00M 10-Q · filed 2009-10-29 | |
| 2008-06-30 | -$14.00M 10-Q · filed 2009-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |